BEAM FY 2021 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$52M+215916.7% YoY

Gross Profit

-$180M-347.8% margin

Operating Income

-$392M-757.0% margin

Net Income

-$371M-714.9% margin

EPS (Diluted)

$-5.77

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$113M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$648M

Stockholders' Equity

$827M

Cash & Equivalents

$560M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$24,000	+215916.7%
Gross Profit	-$180M	-$103M	-74.8%
Operating Income	-$392M	-$133M	-195.6%
Net Income	-$371M	-$195M	-90.5%